Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Metastatic × irinotecan sucrosofate × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 9 Stomach Neoplasms 3 Colorectal Neoplasms 3 Biliary Tract Neoplasms 3 Small Cell Lung Carcinoma 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Rectal Neoplasms 2 Osteosarcoma 2 Neoplasms 2 Neoplasm Metastasis 2 Cholangiocarcinoma 2 Wilms Tumor 1 Small Bowel Adenocarcinoma 1 Sarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Peritoneal Neoplasms 1 PDAC - Pancreatic Ductal Adenocarcinoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Nasopharyngeal Carcinoma 1 Metastatic Adenocarcinoma of the Pancreas 1 Malignant Ascites 1 Locally Advanced Rectal Cancer 1 Locally Advanced Pancreatic Carcinoma(LAPC) 1 Hepatoblastoma 1 Gastrointestinal Neoplasms 1 Gastroesophageal Junction Adenocarcinoma 1 Gastro-enteropancreatic neuroendocrine tumor 1

Interventions

Fulvestrant 3 Letrozole 2 tusamitamab ravtansine 1 trastuzumab deruxtecan 1 ribociclib 1 irinotecan sucrosofate 1 exemestane 1 abemaciclib 1 Zoledronic Acid 1 Tamoxifen 1 Paclitaxel 1 Neoadjuvant Therapy 1 Liposomes 1 Irinotecan 1 Gemcitabine 1 Anastrozole 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03328884 2025-04-23

Phenomenal

MedSIR

Phase 2 Completed

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡